A detailed history of Roosevelt Investment Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Roosevelt Investment Group LLC holds 42,114 shares of LLY stock, worth $32.3 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares
42,114
Previous 42,114 -0.0%
Holding current value
$32.3 Million
Previous $13.7 Million 0.27%
% of portfolio
0.98%
Previous 0.98%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$221.6 - $272.71 $221 - $272
-1 Reduced -0.0%
42,114 $9.73 Million
Q2 2021

Aug 11, 2021

BUY
$180.55 - $233.54 $34,846 - $45,073
193 Added 0.46%
42,115 $9.67 Million
Q1 2021

May 04, 2021

BUY
$164.32 - $212.72 $21,197 - $27,440
129 Added 0.31%
41,922 $7.83 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $41,094 - $54,378
315 Added 0.76%
41,793 $7.06 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $5.66 Million - $6.55 Million
38,700 Added 1393.09%
41,478 $6.14 Million
Q2 2020

Aug 11, 2020

BUY
$136.42 - $164.18 $30,694 - $36,940
225 Added 8.81%
2,778 $456,000
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $11,426 - $12,429
107 Added 4.37%
2,553 $286,000
Q2 2019

Aug 08, 2019

SELL
$110.79 - $129.32 $18,723 - $21,855
-169 Reduced 6.46%
2,446 $271,000
Q1 2019

May 09, 2019

SELL
$111.31 - $131.02 $14,804 - $17,425
-133 Reduced 4.84%
2,615 $339,000
Q4 2018

Feb 05, 2019

SELL
$105.9 - $118.64 $12,284 - $13,762
-116 Reduced 4.05%
2,748 $318,000
Q3 2018

Nov 09, 2018

SELL
$85.86 - $107.31 $6,353 - $7,940
-74 Reduced 2.52%
2,864 $307,000
Q1 2018

May 08, 2018

SELL
$74.21 - $87.6 $68,273 - $80,592
-920 Reduced 23.85%
2,938 $227,000
Q4 2017

Feb 08, 2018

BUY
$81.94 - $87.89 $18,846 - $20,214
230 Added 6.34%
3,858 $326,000
Q3 2017

Nov 08, 2017

BUY
$77.07 - $85.54 $34,296 - $38,065
445 Added 13.98%
3,628 $310,000
Q2 2017

Aug 10, 2017

BUY
N/A
3,183
3,183 $262,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Roosevelt Investment Group LLC Portfolio

Follow Roosevelt Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roosevelt Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roosevelt Investment Group LLC with notifications on news.